Lower Serum L-Tryptophan Availability in Depression as a Marker of a More Generalized Disorder in Protein Metabolism

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Neuropsychopharmacology

• Publication date

  1996-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0893-133X(95)00181-CPMID 8873107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breakfast meal composition influences plasma tryptophan to large neutral amino acid ratios of healthy lean young men

  2005cited by this paper
• Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline

  2004cited by this paper
• Tryptophan depletion causes a rapid lowering of mood in normal males

  2004cited by this paper
• Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder.

  1996cited by this paper
• Seasonal variation in plasma L-tryptophan availability in healthy volunteers. Relationships to violent suicide occurrence.

  1995cited by this paper
• Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine

  1995cited by this paper
• Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls.

  1994cited by this paper
• Haptoglobin phenotypes and gene frequencies in unipolar major depression.

  1994cited by this paper
• Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response.

  1994cited by this paper
• An acute phase protein response in the olfactory bulbectomised rat : effect of sertraline treatment

  1994cited by this paper
• Relationships between lower plasma L-tryptophan levels and immune variables in depression

  1993cited by this paper
• Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression.

  1993cited by this paper
• Tryptophan-deficient diet and amino acid drink deplete plasma tryptophan and induce a relapse of depression in susceptible patients.

  1992cited by this paper
• Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness.

  1992cited by this paper
• Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness.

  1992cited by this paper
• Elevated levels of acute phase plasma proteins in major depression.

  1992cited by this paper
• Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.

  1991cited by this paper
• Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.

  1991cited by this paper
• Anthropometric and biochemical assessment of the nutritional state in depression: evidence for lower visceral protein plasma levels in depression.

  1991cited by this paper
• Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

  1991cited by this paper
• Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.

  1990cited by this paper
• Interleukin-6: historical background, genetics and biological significance.

  1990cited by this paper
• The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients.

  1990cited by this paper
• Interleukin-6 and the acute phase response.

  1990cited by this paper
• Olfactory bulbectomy alters alpha-1 acid glycoprotein levels in rat plasma.

  1990cited by this paper
• Effects of dexamethasone on the availability of L-tryptophan and on the insulin and FFA concentrations in unipolar depressed patients.

  1990cited by this paper
• Suppressant effects of dexamethasone on the availability of plasma L‐tryptophan and tyrosine in healthy controls and in depressed patients

  1990cited by this paper
• Albumin decrement in depression and cholesterol decrement in mania.

  1990cited by this paper
• Influence of cerebral blood flow on tryptophan uptake into brain

  1990cited by this paper
• Decreased plasma tryptophan levels in major depression.

  1989cited by this paper
• Clinical and nutritional aspects of changes in acute-phase proteins during inflammation

  1989cited by this paper
• Interleukin‐1 and Interleukin‐6 Stimulate Acute‐Phase Protein Production in Primary Mouse Hepatocytes

  1989cited by this paper
• Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects.

  1989cited by this paper
• Altered tryptophan and neopterin metabolism in cancer patients treated with recombinant interleukin 2.

  1989cited by this paper
• Effects of a suppression test dose of dexamethasone on tryptophan metabolism and disposition in the rat.

  1989cited by this paper
• Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

  1989cited by this paper
• Current concepts of protein turnover and amino acid transport in liver and skeletal muscle during sepsis.

  1988cited by this paper
• Regulation of rabbit acute phase protein biosynthesis by monokines.

  1988cited by this paper
• Bioavailability of Amino Acids and Amino Acid Precursors for Neurotransmitter Action: The Role of Hormones

  1988cited by this paper
• Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia.

  1987cited by this paper
• Twenty-four-hour variations in rat blood and brain levels of the aromatic and branched-chain amino acids: chronic effects of dietary protein content.

  1987cited by this paper
• Normal plasma free amino acid values in adults: the influence of some common physiological variables.

  1985cited by this paper
• 1 – Progress in Plasma Proteins

  1984cited by this paper
• Plasma amino acid responses in humans to evening meals of differing nutritional composition.

  1982cited by this paper
• Plasma tryptophan and five other amino acids in depressed and normal subjects.

  1981cited by this paper
• Branched chain amino acid administration and metabolism during starvation, injury, and infection.

  1979cited by this paper
• Factors affecting plasma amino acid concentrations in control subjects.

  1979cited by this paper
• Tryptophan transport through the blood-brain barrier: in vivo measurement of free and albumin-bound amino acid.

  1979cited by this paper
• EFFECT OF ALBUMIN BINDING AND AMINO ACID COMPETITION ON TRYPTOPHAN UPTAKE INTO BRAIN 1

  1977cited by this paper
• RAPID EFFECTS OF ENVIRONMENTAL DISTURBANCE ON RAT PLASMA UNESTERIFIED FATTY ACID AND TRYPTOPHAN CONCENTRATIONS AND THEIR PREVENTION BY ANTILIPOLYTIC DRUGS

  1975cited by this paper
• THE EFFECTS OF PRECURSOR LOADING IN THE CEREBRAL METABOLISM OF 5‐HYDROXYINDOLES

  1968cited by this paper
• Development of a rating scale for primary depressive illness.

  1967cited by this paper
• The specific binding of L-tryptophan to serum albumin.

  1958cited by this paper

• The kynurenine pathway in relation to depression and anhedonia symptom severity among women with HIV.

  2026cites this paper
• Comparison of the Kynurenine/Tryptophan Ratio with the Beck Suicide Intent Scale in Patients Admitted to the Emergency Department Due to Suicide Attempt

  2025cites this paper
• The tryptophan catabolite or kynurenine pathway in autism spectrum disorder; a systematic review and meta‐analysis

  2023cites this paper
• Tryptophan-kynurenine metabolic characterization in the gut and brain of depressive-like rats induced by chronic restraint stress.

  2023cites this paper
• Tryptophan catabolites, inflammation, and insulin resistance as determinants of chronic fatigue syndrome and affective symptoms in long COVID

  2023cites this paper
• Sex Differences in Tryptophan Metabolism: A Systematic Review Focused on Neuropsychiatric Disorders

  2023cites this paper
• The Tryptophan Catabolite or Kynurenine Pathway's Role in Major Depression.

  2022cites this paper
• Interactive relationship between Trp metabolites and gut microbiota: The impact on human pathology of disease

  2022cites this paper
• The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• The Tryptophan Catabolite or Kynurenine Pathway in a Major Depressive Episode with Melancholia, Psychotic Features and Suicidal Behaviors: A Systematic Review and Meta-Analysis

  2022cites this paper
• The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis

  2022cites this paper
• Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression

  2021cites this paper
• Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders

  2021cites this paper
• The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

  2020cites this paper
• Albumin is a secret factor involved in multidirectional interactions among the serotoninergic, immune and endocrine systems that supervises the mechanism of CYP1A and CYP3A regulation in the liver.

  2020cites this paper
• An Overview of the Heterogeneity of Major Depressive Disorder: Current Knowledge and Future Prospective

  2020cites this paper
• Inverse association between serum albumin and depressive symptoms among drug-free individuals with a recent suicide attempt

  2019cites this paper
• A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls.

  2018cites this paper
• A New Role for Vitamin D Binding Protein in Bipolar Disorder

  2017cites this paper
• The amino acid profile in blood plasma of young boys with autism.

  2017cites this paper
• Total oxidant–antioxidant and paraoxonase-1 levels in premenstrual dysphoric disorder: a follow-up study

  2017cites this paper
• Maternal Weaning Modulates Emotional Behavior and Regulates the Gut-Brain Axis

  2016cites this paper
• 13C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder

  2015cites this paper
• Albumin and depression in elderly stroke survivors: An observational cohort study.

  2015cites this paper
• A Meta-Analysis of Oxidative Stress Markers in Depression

  2015cites this paper
• The Link between Psychological Stress and Autoimmune Response in Children.

  2015cites this paper
• Biological phenotypes underpin the physio‐somatic symptoms of somatization, depression, and chronic fatigue syndrome

  2014cites this paper
• Urinary peptidomics identifies potential biomarkers for major depressive disorder.

  2014cites this paper
• Antidepressant Response Metabonomics

  2014cites this paper
• Depressive Symptoms in Crohn's Disease: Relationship with Immune Activation and Tryptophan Availability

  2013cites this paper
• Research review: the role of cytokines in depression in adolescents: a systematic review.

  2013cites this paper
• The possible role of the kynurenine pathway in anhedonia in adolescents

  2012cites this paper
• Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway.

  2012cites this paper
• Psychobiological correlates of allostatic overload in a healthy population.

  2012cites this paper
• Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.

  2012cites this paper
• The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.

  2011cites this paper
• Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity.

  2011cites this paper
• Drug-Induced Diseases: Depression

  2011cites this paper
• Shifts in the balance of brain tryptophan metabolism due to age and systemic administration of lipopolysaccharide

  2010cites this paper
• Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression.

  2010cites this paper
• Neuropathology of Post-stroke Depression: Possible Role of Inflammatory Molecules and Indoleamine 2,3-dioxygenase

  2010cites this paper
• The possible role of the kynurenine pathway in adolescent depression with melancholic features.

  2010cites this paper
• The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

  2010cites this paper
• Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice

  2009cites this paper
• Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response

  2009cites this paper
• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

  2009cites this paper
• A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression

  2008cites this paper
• Nutrition and depression: A review of the evidence

  2008cites this paper
• Chronic intraperitoneal injection of interferon‐α reduces serotonin levels in various regions of rat brain, but does not change levels of serotonin transporter mRNA, nitrite or nitrate

  2006cites this paper
• Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls

  2004cites this paper
• Anhaltende, manische und bipolare affektive Störungen

  2003cites this paper
• Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients.

  2003cites this paper
• Depressive Episode und rezidivierende depressive Störung

  2003cites this paper
• Nitric oxide involvement in depression during interferon-alpha therapy.

  2003cites this paper
• Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system.

  2002cites this paper
• Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation.

  2002cites this paper
• Cytokines and depression.

  2002cites this paper
• Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

  2002cites this paper
• Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism

  2002cites this paper
• Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy

  2002cites this paper
• Pathophysiology of autism: current opinions

  2002cites this paper
• Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation

  2001cites this paper
• Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression

  2001cites this paper
• The relationship of depression and stressors to immunological assays: a meta-analytic review.

  2001cites this paper
• Interferons, serotonin and neurotoxicity

  2000cites this paper
• Peripheral Markers of Serotonergic and Noradrenergic Function in Post-Pubertal, Caucasian Males with Autistic Disorder

  2000cites this paper
• Cytokine hypothesis of overtraining: a physiological adaptation to excessive stress?

  2000cites this paper
• Neuro-Immune Interactions in Neurologic and Psychiatric Disorders

  2000cites this paper
• Serotonin-Immune Interactions in Major Depression

  2000cites this paper
• Serotonergic and Noradrenergic Markers of Post-Traumatic Stress Disorder with and without Major Depression

  1999cites this paper
• The inflammatory response system activation model of major depression

  1999cites this paper
• The influence of psychological stress on total serum protein and patterns obtained in serum protein electrophoresis

  1998cites this paper
• Serotonin-immune interactions in detoxified chronic alcoholic patients without apparent liver disease: activation of the inflammatory response system and lower plasma total tryptophan.

  1998cites this paper
• Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT

  1998cites this paper
• The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

  1998cites this paper
• Lower total serum protein, albumin, and beta- and gamma-globulin in major and treatment-resistant depression: effects of antidepressant treatments.

  1996cites this paper
• Regulatory Mechanisms in Biosystems

  year unknowncites this paper
• Acute tryptophan depletion affects brain-gut responses in irritable bowel syndrome patients and controls

  year unknowncites this paper